These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The new serology of histocompatibility testing and its significance in human renal transplantation. Braun WE Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083 [No Abstract] [Full Text] [Related]
3. Correlation between mixed lymphocyte culture in compatibility and cadaver kidney graft rejection. Thomsen M; Dickmeiss E Scand J Urol Nephrol Suppl; 1977; (42):40-3. PubMed ID: 150639 [TBL] [Abstract][Full Text] [Related]
4. Renal transplantation between HLA identical siblings. Comparison with transplants from HLA semi-identical related donors. Cheigh JS; Chami J; Stenzel KH; Riggio RR; Saal S; Mouradian JA; Fotino M; Stubenbord WT; Rubin AL N Engl J Med; 1977 May; 296(18):1030-4. PubMed ID: 139567 [TBL] [Abstract][Full Text] [Related]
5. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation. Albrechtsen D; Arnesen E; Solheim BG; Thorsby E Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432 [No Abstract] [Full Text] [Related]
6. Is HL-A typing of clinical significance in cadaver renal transplantation? Belzer FO; Perkins HA; Fortmann JL; Kountz SL; Salvatierra O; Cochrum KC; Payne R Lancet; 1974 Apr; 1(7861):774-7. PubMed ID: 4132709 [No Abstract] [Full Text] [Related]
7. The importance of non-HLA systems and the feasibility of the use of unrelated donors in bone marrow transplantation. van Rood JJ; van Leeuwen A; Goulmy E; Termijtelen A; Bradley BA; Brand A; Eernisse JG Transplant Proc; 1978 Mar; 10(1):47-51. PubMed ID: 24909 [No Abstract] [Full Text] [Related]
8. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Reinsmoen NL; Matas AJ Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534 [TBL] [Abstract][Full Text] [Related]
11. Mixed leukocyte culture incompatibility index for donor-recipient selection in kidney transplantation. Uehling DT; Segall M; Hussey JL; Wank R; Kan CM; Bach FH J Urol; 1977 Jan; 117(1):7-9. PubMed ID: 137331 [TBL] [Abstract][Full Text] [Related]
12. Immunologic factors determining survival of cadaver-kidney transplants. The effect of HLA serotyping, cytotoxic antibodies and blood transfusions on graft survival. Vincenti F; Duca RM; Amend W; Perkins HA; Cochrum KC; Feduska NJ; Salvatierra O N Engl J Med; 1978 Oct; 299(15):793-8. PubMed ID: 151230 [TBL] [Abstract][Full Text] [Related]
13. [HLA-compatibility testing in kidney transplantation--past, present and future]. van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582 [No Abstract] [Full Text] [Related]
14. A single-center experience with six-antigen-matched kidney transplants. Washburn WK; Shaffer D; Conway P; Madras PN; Monaco AP Arch Surg; 1995 Mar; 130(3):277-82. PubMed ID: 7887794 [TBL] [Abstract][Full Text] [Related]
15. Influence of immunosuppressive therapy, HLA matching and donor age on long term cadaveric pediatric renal allograft survival. Groenewoud AF; Persijn GG; D'Amaro J; de Lange P; Cohen B Transplant Proc; 1989 Feb; 21(1 Pt 2):1683-4. PubMed ID: 2652551 [No Abstract] [Full Text] [Related]